Menu

MedTech and Pharma News



Curadev signs STING antagonist deal with Bayer
Curadev Pharma Pvt. Ltd. licensed Bayer AG exclusive rights to small-molecule antagonists of the stimulator of interferon genes (STING) for the treatment of lung, cardiovascular, and inflammatory diseases.
Strategic Transactions - Biotech - March 27, 2020
Abbott Launches Five-Minute POC Rapid COVID-19 Test
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a...
Medtech Insight - March 27, 2020
In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General...
Medtech Insight - March 27, 2020
In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Is Already Doing That
President Trump on 27 March finally pulled the trigger on using his powers under the Device Production Act, forcing General...
Scrip - March 27, 2020
Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.
Medtech Insight - March 27, 2020
Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows
Health-system pharmacist organization assesses the evidence behind off-label use of existing drugs for COVID-19, along with top investigational prospects like...
Scrip - March 27, 2020
Deal Watch: Coronavirus Collaborations Reflect Industry’s Full Press Pandemic Response
Deals involving Hoth/Voltron, Vir/Xencor, Akers/Premas, WPD/CNS address coronavirus outbreak. Separately, Roche and Forge hope to develop a novel antibiotic for...
Scrip - March 27, 2020
Unpacking The $2.2Tn Stimulus Act: Boosts To Medtech And Diagnostics To Fight Coronavirus
A $2.2tn coronavirus stimulus package signed into law by President Trump on 27 March will distribute billions of dollars to...
Medtech Insight - March 27, 2020
COVID-19: FDA Offers Cautionary FAQs On 3D Printing Of Key Medical Supplies
In a 28 March FAQ document, the US agency cautions manufacturers on the 3D printing of medical devices to address...
Medtech Insight - March 27, 2020
COVID-19: FDA Issues ‘Cautionary’ Guidance On 3D Printing Of Key Medical Supplies
In a 28 March guidance document, the US agency cautions manufacturers on the 3D printing of medical devices to address...
Medtech Insight - March 27, 2020
In Pandemic Response, Quality Experts Advise Drug Manufacturers Move Products To Local Sites
AstraZeneca emptied its warehouses in January. “We said, OK let us pack everything and get it out in the door,”...
HBW Insight - March 27, 2020
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Pink Sheet - March 27, 2020
Cipla First On Generic Nexium Formulation
India’s Cipla has received the first US approval for a generic rival to Nexium delayed-release oral suspension in the US...
Scrip - March 27, 2020
Nivagen Raises Cash To Fuel Growth
California-based Nivagen is continuing to raise money to push through a number of generic launches in the US this year...
Scrip - March 27, 2020
Pink Sheet Podcast: Another Coronavirus Stimulus Bill, Remdesivir’s Brief Orphan Status, Teva Sues Over Copaxone Regulation
Pink Sheet editor and reporters discuss the effects of the latest coronavirus stimulus package on pharma, Gilead’s request for rescission...
Pink Sheet - March 27, 2020
Quality Experts Advise Industry To Move Products To Local Sites In Responding To COVID-19
Quality experts with AstraZeneca and Thermo Fisher describe how their companies are responding to the COVID-19 pandemic – but urge...
Pink Sheet - March 27, 2020
Zolgensma and Seven Other Products Get CHMP Thumbs Up
Zolgensma should receive a conditional approval, says the European Medicines Agency’s drug evaluation committee, the CHMP.
Pink Sheet - March 27, 2020
More Time For EU Nitrosamine Evaluations Due To COVID-19
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
Pink Sheet - March 27, 2020
A Backstage View Of Roche’s Recent Collaborations
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind...
Scrip - March 27, 2020
Novartis Close To EU Approval For Zolgensma At Last
Novartis’s AveXis unit has received a CHMP nod for the spinal muscular atrophy gene therapy at its latest meeting, sending...
Scrip - March 27, 2020
England's NICE To Focus On COVID-19 And Other Critical Therapies
The health technology assessment institute is taking a virtual approach to meetings and has said that it can provide free...
Pink Sheet - March 27, 2020
UK Biotechs Seek Government Help As Economic ‘Heart Attack’ Threatens Sector
Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.
Scrip - March 27, 2020
The Race Is On To Launch COVID-19 Antibody Home-Test In The UK
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution...
HBW Insight - March 27, 2020
A Look At The New Leadership Team At NICE
The new appointments to the top jobs at NICE may bring continuity at a challenging time for the institute, but...
Pink Sheet - March 27, 2020
Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up
The French drugmaker has joined the likes of Moderna, BioNTech and CureVac in advancing an mRNA vaccine against the virus...
Scrip - March 27, 2020
UK Attacks Pandemic With Funding For Drug And Vaccine Trials
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including...
Pink Sheet - March 27, 2020
ECHA Supporting Efforts To Speed Disinfectants To European Market
The European Chemicals Agency is working to develop a centralized, expedited authorization process to increase the availability of disinfectants to...
HBW Insight - March 27, 2020
Australia Proposes ‘Carving Out’ Certain Software Products From Medtech Regs
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that...
Medtech Insight - March 27, 2020
Did The UK Government Really Spurn EU Ventilator Procurement Support?
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time...
Medtech Insight - March 27, 2020
Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug
As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind...
Scrip - March 27, 2020
Recordati’s OTC Sales Lifted by Acquisitions And Italy
Italy's Recordati enjoyed strong growth in its home market and abroad, lifting OTC group sales in 2019.
HBW Insight - March 27, 2020
Will The COVID-19 Pandemic Shake Up Access To Medicines?
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to...
Pink Sheet - March 27, 2020
UK Reveals How To Access Fast-Track Approval Of Devices During COVID-19 Outbreak
How to get non-CE-marked medical devices onto the UK market at speed
Medtech Insight - March 27, 2020
The 11 EU Standards Freely Available In COVID-19 Fight And Where To Find Them
Manufacturers normally must pay to access medtech and personal protective equipment standards. But now some are freely available in the...
Medtech Insight - March 27, 2020
UK's PAGB Appoints Michelle Riddalls As New CEO
HBW Insight exclusive: UK consumer healthcare industry association, PAGB, appoints Michelle Riddalls as its new CEO.
HBW Insight - March 27, 2020
COVID-19 Lesson: India Earmarks $1.3bn To Reduce Dependence On China
In a bid to ensure long-term medicines security, the Indian government has earmarked $1.32bn to promote domestic production of 53...
Pink Sheet - March 27, 2020
India Lockdown: Early Signs of Manufacturing Strains But Resolutions Underway
Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government...
Scrip - March 27, 2020
CrystalGenomics Eyes COVID-19 Trials As Hopes Rise For Ivaltinostat
Although the pandemic could slightly delay CrystalGenomics’ business and R&D plans, the South Korean biotech is still hopeful this year...
Scrip - March 27, 2020
QUOTED. 27 March 2020. US FDA.
Manufacturers of some medical face masks won't need US Food and Drug Administration clearance to sell their wares under an...
Medtech Insight - March 27, 2020

Abbott Launches Five-Minute POC Rapid COVID-19 Test
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a...
Medtech Insight - March 27, 2020
In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General...
Medtech Insight - March 27, 2020
Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.
Medtech Insight - March 27, 2020
Unpacking The $2.2Tn Stimulus Act: Boosts To Medtech And Diagnostics To Fight Coronavirus
A $2.2tn coronavirus stimulus package signed into law by President Trump on 27 March will distribute billions of dollars to...
Medtech Insight - March 27, 2020
COVID-19: FDA Offers Cautionary FAQs On 3D Printing Of Key Medical Supplies
In a 28 March FAQ document, the US agency cautions manufacturers on the 3D printing of medical devices to address...
Medtech Insight - March 27, 2020
COVID-19: FDA Issues ‘Cautionary’ Guidance On 3D Printing Of Key Medical Supplies
In a 28 March guidance document, the US agency cautions manufacturers on the 3D printing of medical devices to address...
Medtech Insight - March 27, 2020
Australia Proposes ‘Carving Out’ Certain Software Products From Medtech Regs
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that...
Medtech Insight - March 27, 2020
Did The UK Government Really Spurn EU Ventilator Procurement Support?
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time...
Medtech Insight - March 27, 2020
UK Reveals How To Access Fast-Track Approval Of Devices During COVID-19 Outbreak
How to get non-CE-marked medical devices onto the UK market at speed
Medtech Insight - March 27, 2020
The 11 EU Standards Freely Available In COVID-19 Fight And Where To Find Them
Manufacturers normally must pay to access medtech and personal protective equipment standards. But now some are freely available in the...
Medtech Insight - March 27, 2020
QUOTED. 27 March 2020. US FDA.
Manufacturers of some medical face masks won't need US Food and Drug Administration clearance to sell their wares under an...
Medtech Insight - March 27, 2020

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Is Already Doing That
President Trump on 27 March finally pulled the trigger on using his powers under the Device Production Act, forcing General...
Scrip - March 27, 2020
Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows
Health-system pharmacist organization assesses the evidence behind off-label use of existing drugs for COVID-19, along with top investigational prospects like...
Scrip - March 27, 2020
Deal Watch: Coronavirus Collaborations Reflect Industry’s Full Press Pandemic Response
Deals involving Hoth/Voltron, Vir/Xencor, Akers/Premas, WPD/CNS address coronavirus outbreak. Separately, Roche and Forge hope to develop a novel antibiotic for...
Scrip - March 27, 2020
Cipla First On Generic Nexium Formulation
India’s Cipla has received the first US approval for a generic rival to Nexium delayed-release oral suspension in the US...
Scrip - March 27, 2020
Nivagen Raises Cash To Fuel Growth
California-based Nivagen is continuing to raise money to push through a number of generic launches in the US this year...
Scrip - March 27, 2020
A Backstage View Of Roche’s Recent Collaborations
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind...
Scrip - March 27, 2020
Novartis Close To EU Approval For Zolgensma At Last
Novartis’s AveXis unit has received a CHMP nod for the spinal muscular atrophy gene therapy at its latest meeting, sending...
Scrip - March 27, 2020
UK Biotechs Seek Government Help As Economic ‘Heart Attack’ Threatens Sector
Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.
Scrip - March 27, 2020
Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up
The French drugmaker has joined the likes of Moderna, BioNTech and CureVac in advancing an mRNA vaccine against the virus...
Scrip - March 27, 2020
Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug
As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind...
Scrip - March 27, 2020
India Lockdown: Early Signs of Manufacturing Strains But Resolutions Underway
Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government...
Scrip - March 27, 2020
CrystalGenomics Eyes COVID-19 Trials As Hopes Rise For Ivaltinostat
Although the pandemic could slightly delay CrystalGenomics’ business and R&D plans, the South Korean biotech is still hopeful this year...
Scrip - March 27, 2020

Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Pink Sheet - March 27, 2020
Pink Sheet Podcast: Another Coronavirus Stimulus Bill, Remdesivir’s Brief Orphan Status, Teva Sues Over Copaxone Regulation
Pink Sheet editor and reporters discuss the effects of the latest coronavirus stimulus package on pharma, Gilead’s request for rescission...
Pink Sheet - March 27, 2020
Quality Experts Advise Industry To Move Products To Local Sites In Responding To COVID-19
Quality experts with AstraZeneca and Thermo Fisher describe how their companies are responding to the COVID-19 pandemic – but urge...
Pink Sheet - March 27, 2020
Zolgensma and Seven Other Products Get CHMP Thumbs Up
Zolgensma should receive a conditional approval, says the European Medicines Agency’s drug evaluation committee, the CHMP.
Pink Sheet - March 27, 2020
More Time For EU Nitrosamine Evaluations Due To COVID-19
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
Pink Sheet - March 27, 2020
England's NICE To Focus On COVID-19 And Other Critical Therapies
The health technology assessment institute is taking a virtual approach to meetings and has said that it can provide free...
Pink Sheet - March 27, 2020
A Look At The New Leadership Team At NICE
The new appointments to the top jobs at NICE may bring continuity at a challenging time for the institute, but...
Pink Sheet - March 27, 2020
UK Attacks Pandemic With Funding For Drug And Vaccine Trials
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including...
Pink Sheet - March 27, 2020
Will The COVID-19 Pandemic Shake Up Access To Medicines?
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to...
Pink Sheet - March 27, 2020
COVID-19 Lesson: India Earmarks $1.3bn To Reduce Dependence On China
In a bid to ensure long-term medicines security, the Indian government has earmarked $1.32bn to promote domestic production of 53...
Pink Sheet - March 27, 2020

Deals Shaping The Medical Industry, March 2020
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of...
In Vivo - March 23, 2020
EU Health Innovation Partnership Reflects Medtech’s Role In Unmet Needs
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase...
In Vivo - March 23, 2020

Takeda divests some non-core and OTC assets to Hypera for $825M
Takeda Pharmaceutical Co. Ltd. divested 18 OTC and prescription drug products to Brazilian pharmaco Hypera SA, which paid $825M. Takeda will divest the rights, title, and interest to the marketed products that are sold in Brazil, Mexico, Argentina, Colombia, Ecuador, Panama and Peru. It will continue to manufacture and supply the drugs to Hypera.
Strategic Transactions - March 4, 2020

In Pandemic Response, Quality Experts Advise Drug Manufacturers Move Products To Local Sites
AstraZeneca emptied its warehouses in January. “We said, OK let us pack everything and get it out in the door,”...
HBW Insight - March 27, 2020
The Race Is On To Launch COVID-19 Antibody Home-Test In The UK
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution...
HBW Insight - March 27, 2020
ECHA Supporting Efforts To Speed Disinfectants To European Market
The European Chemicals Agency is working to develop a centralized, expedited authorization process to increase the availability of disinfectants to...
HBW Insight - March 27, 2020
Recordati’s OTC Sales Lifted by Acquisitions And Italy
Italy's Recordati enjoyed strong growth in its home market and abroad, lifting OTC group sales in 2019.
HBW Insight - March 27, 2020
UK's PAGB Appoints Michelle Riddalls As New CEO
HBW Insight exclusive: UK consumer healthcare industry association, PAGB, appoints Michelle Riddalls as its new CEO.
HBW Insight - March 27, 2020
Back to the top Back to the top